Colchicine plus standard care vs placebo or usual careAll‐cause mortality assessed up to day 28 · individuals with moderate or severe COVID‐191 finding from 1 reviewColchicine for the treatment of COVID‐19 2021 · Cochrane Headline outcomes onlyno estimate extracted2 studies · 11445 participantsModerate